The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.32
Bid: 42.22
Ask: 42.28
Change: -0.02 (-0.05%)
Spread: 0.06 (0.142%)
Open: 41.72
High: 42.74
Low: 41.72
Prev. Close: 42.34
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

2 Jul 2019 07:00

RNS Number : 1070E
Assura PLC
02 July 2019
 

2 July 2019

Assura plc

 

Trading Update

For the first quarter to 30 June 2019

 

Assura's high-quality portfolio and pipeline reinforced; GPI integration progressing well

 

Assura plc ("Assura"), the leading primary care property investor and developer, today announces its Trading Update for the first quarter to 30 June 2019.

 

Jonathan Murphy, CEO, said:

"Assura made good progress in the first quarter, further enhancing our high-quality portfolio of primary care properties. Our immediate pipeline of developments and acquisitions has never been stronger, while we disposed of 12 properties that were held for sale for cash proceeds of £17 million which was above book value.

 

"In May, we completed the purchase of primary care developer GPI and welcomed a talented new team into Assura. The acquisition boosted our immediate and extended development pipeline by an initial £92 million.

 

"We continue to source exciting opportunities to grow our portfolio and provide more of the fit-for-purpose primary care facilities that the NHS urgently needs to benefit patients and reduce pressure on the organisation.

 

"We remain confident in our outlook for the full year and in our longer-term prospects."

 

Developments and strategic acquisitions strengthen market-leading portfolio

· One development completed (Darley Dale) at a cost of £2.3 million and two moved to on site (Canterbury and St Leonards); total of 12 developments on site at the period end with a total development cost of £58 million.

· Two acquisitions completed in the period at a cost of £5.5 million.

· 12 disposals completed for £17 million cash consideration at a small premium to book value.

 

GPI acquisition expands pipeline

· Current portfolio of 554 properties.

· Immediate development pipeline of £77 million.

· Immediate acquisitions pipeline increased to £64 million, compared with £41 million at March 2019.

· Total immediate pipeline value, including on site developments, of £199 million up from £142 million at the year end.

 

Active portfolio management delivering value

· Six lease re-gears agreed on £0.3 million of rent, adding weighted average of 10 years WAULT on those properties.

· Annualised rent roll at £102.1 million post disposals.

 

Strong financial position

· As at 30 June 2019 gross debt £730 million with undrawn facilities of £230 million plus cash balance of £47.5 million.

 

 

 

ENDS

For further information, please contact:

 

Assura plc:

Jayne Cottam, CFOOrla Ball, Company SecretaryDavid Purcell, Head of Financial Reporting

 

Tel: 01925 420 660

 

Finsbury:

Gordon Simpson

James Thompson

 

Tel: 0207 251 3801

 

This announcement contains inside information as defined in Article 7 of the EU Market Abuse Regulation No 596/2014 and has been announced in accordance with the Company's obligations under Article 17 of that Regulation.

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 31 March 2019, Assura's property portfolio was valued at £1,979 million.

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFLRDEILIIA
Date   Source Headline
29th Jun 20237:00 amRNSCompletion of 100th development
27th Jun 20234:18 pmRNSHolding(s) in Company
27th Jun 20238:33 amRNSHolding(s) in Company
15th Jun 20237:31 amRNSScrip Calculation Price
14th Jun 20239:01 amRNSHolding(s) in Company
12th Jun 20234:23 pmRNSDirector/PDMR Shareholding
5th Jun 202310:54 amRNSDirector/PDMR Shareholding
2nd Jun 20237:00 amRNSAnnual Report & Notice of AGM
1st Jun 20237:00 amRNSNotice of Dividend
23rd May 20237:00 amRNSAssura Full Year Results 2023
12th May 20237:00 amRNSNotice of Results
10th May 202310:53 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSTotal Voting Rights
25th Apr 20234:12 pmRNSHolding(s) in Company
17th Apr 20234:06 pmRNSDirector/PDMR Shareholding
11th Apr 20238:43 amRNSDirector/PDMR Shareholding
11th Apr 20237:00 amRNSScrip Dividend Declaration
16th Mar 202310:13 amRNSScrip Calculation Price
13th Mar 20237:00 amRNSMSCI ESG rating upgrade and energy reduction pilot
7th Mar 202310:43 amRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSNotice of Dividend
15th Feb 20231:51 pmRNSHolding(s) in Company
7th Feb 20239:57 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTotal Voting Rights
26th Jan 20231:48 pmRNSHolding(s) in Company
16th Jan 20237:00 amRNSTrading Update
13th Jan 20232:55 pmRNSDirector/PDMR Shareholding
9th Jan 202311:33 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSScrip Dividend Declaration
15th Dec 20229:07 amRNSScrip calculation price
6th Dec 20229:03 amRNSDirector/PDMR Shareholding
1st Dec 20227:00 amRNSDividend Declaration
22nd Nov 20227:00 amRNSDelivering continued growth
15th Nov 202212:15 pmRNSHolding(s) in Company
8th Nov 20229:02 amRNSDirector/PDMR Shareholding
1st Nov 20222:02 pmRNSHolding(s) in Company
31st Oct 20228:43 amRNSTotal Voting Rights
17th Oct 202212:10 pmRNSDirector/PDMR Shareholding
11th Oct 20221:49 pmRNSHolding(s) in Company
10th Oct 20227:00 amRNSScrip Dividend Declaration
7th Oct 202210:14 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSTrading Update
15th Sep 20227:00 amRNSScrip calculation price
14th Sep 20225:37 pmRNSDirector/PDMR Shareholding
13th Sep 20224:28 pmRNSHolding(s) in Company
1st Sep 20227:00 amRNSDividend Declaration
8th Aug 202212:51 pmRNSDirector/PDMR Shareholding
29th Jul 20229:27 amRNSTotal Voting Rights
18th Jul 20222:53 pmRNSDirector/PDMR Shareholding
13th Jul 20225:17 pmRNSExercise of Nil Cost Options under PSP

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.